A phase III study of PALO in pediatric patients receiving highly and moderately emetogenic chemotherapy.
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2016
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 01 Dec 2016 Status changed from not yet recruiting to recruiting.
- 08 Jul 2016 New trial record